gip and glp-1 agonist New strategies for the treatment of obesity metabolic dysfunctions The Effects of Dual GLP-1/GIP
Description
Liraglutide, a GLP-1 agonist, as a new adjunct treatment in Hailey-Hailey disease: a case report
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 trial
Innate immunity in Alzheimers disease
Optimizing Nutrition, Diet, and Lifestyle Communication in GLP-1 Medication Therapy for Weight Management: A Qualitative Research Study With Registered Dietitians
Li J, Mooney DJ
Combined treatment with glucagon-like peptide-1 receptor agonist Exendin-4 and metformin attenuates breast cancer growth
